Nogra Pharma is available to give comprehensive Project presentations, provide additional Project specific details or confidential information and discuss potential collaborations or out-licensing opportunities with interested companies.
Abstract
Mammalian aryl hydrocarbon receptor (AHR) is a ligand- dependent transcriptionfactor that belongs to the basic helix–loop–helix (bHLH)–PAS family of transcription factors,which are evolutionarily conserved environmental sensors. In the absence of ligands, AHR residesin the cytoplasm in a complex with molecular chaperones such as HSP90, XAP2 and p23. Uponligand binding, AHR translocates into the nuclear compartment, where it dimerizes with its partner protein, AHR nuclear translocator (ARNT), an obligatory partner for the DNA- binding and functional activity. Historically, AHR had mostly been considered as a key intermediary for the detrimental effects of environmental pollutants on the body. However, following the discovery of AHR- mediated functions in various immune cells, as well as the emergence of non- toxic ‘natural’ AHR ligands, this view slowly began to change, and the study of AHR- deficient mice revealed a plethora of important beneficial functions linked to AHR activation. This Review focuses on regulation of the AHR pathway and the barrier- protective roles AHR has in haematopoietic, as well as non- haematopoietic, cells within the intestinal microenvironment. It covers the nature of AHR ligands and feedback regulation of the AHR pathway, outlining the currently known physiological functions in immune, epithelial, endothelial and neuronal cells of the intestine.